Florey Trials

Where neuroscience expertise meets clinical trial excellence

Florey Trials provides a single entry point into Australia’s leading neuroscience ecosystem – connecting sponsors with neuroscience expertise, translational infrastructure, clinical networks and trial delivery.

Our services

We support sponsors and partners across the research spectrum – providing both strategic scientific guidance and execution-ready trial management. Our dedicated project teams remain engaged from a study’s inception to its completion, ensuring trials are managed with the clarity and rigour necessary to meet complex clinical objectives.

Whether you are a global pharmaceutical company, an emerging biotech, a medical device developer or an investigator leading your own study, we tailor our support to what your trial needs – as a full-service partner or for specific stages of your program.

  • Strategy – development advice, scientific input from Florey researchers and clinicians, and protocol and Investigator’s Brochure writing
  • Feasibility – site identification and selection, recruitment planning and engagement with clinical trial networks
  • Start-up – ethics and governance submissions, participant information and consent forms, and site initiation
  • Delivery – project management, monitoring, and safety and pharmacovigilance
  • Evidence – data management, biostatistics and clinical study reports

Some services are delivered through validated partners, coordinated by Florey Trials so you keep a single point of contact throughout.

Support for investigator-initiated trials

Florey researchers and clinician-investigators can draw on our team for protocol development, budgeting, ethics and governance, and trial management, so academic studies are run with the same rigour as commercial trials.

Working alongside global CROs

Where a global trial needs an Australian footprint, we partner with global CROs to provide local operational knowledge and access to Florey expertise. Through the same partnerships, we can give our clients access to sites overseas when their trial needs a global reach.

Australian local sponsor for international companies

For overseas companies without an Australian entity, The Florey can act as the local trial sponsor, taking on the regulatory responsibilities required to run the trial in Australia – including notification to the Therapeutic Goods Administration under the Clinical Trial Notification (CTN) scheme – so you can start without first setting up a local company.

Core capabilities

Specialist brain health and neuroscience expertise

  • Alzheimer’s disease and other dementias
  • Stroke and vascular neurology
  • Parkinson’s and movement disorders
  • Epilepsy
  • Multiple sclerosis and neuroimmunology
  • Motor neurone and neuromuscular disease
  • Mental health
  • Brain and spinal cord injury

Beyond traditional neuroscience

We also connect sponsors with Florey researchers working in critical care neuroscience, peri-operative brain injury, neuroinflammation, neuro-oncology and brain–organ interactions.

Clinical networks and key opinion leader access

Disease-specific clinical networks across stroke, dementia, movement disorders and epilepsy, combined with access to leading clinicians and researchers, help us identify the right sites and investigators, sharpen recruitment insight and refine protocols before a trial begins.

Translational infrastructure

  • Imaging – MRI, CT and PET capabilities
  • Laboratories – GLP-accredited biomarker laboratories and national reference laboratories
  • Recruitment pathways – clinician-researcher referral networks and, where appropriate consent is in place, patient registries

Why we're the right partner

Scientific depth  Connected expertise  End-to-end support 
World-leading neuroscience expertise from The Florey is embedded into the real-world design and delivery of every clinical trial. 

 Our strength lies not only  in understanding complex neurological science, but in applying it with precision to trial design, endpoints, and execution. This is further enhanced by access to unique datasets and translational research capabilities that strengthen data quality, outcomes, and integrity. 

Through embedded networks and partnerships, we connect sponsors and partners to the right expertise at every stage.  

 With deep integration across researchers, clinical partners and trial delivery, we offer a more effective pathway from discovery to delivery. 

From strategic guidance through to execution-ready delivery, Florey Trials provide end-to-end support that enables sponsors and partners to move forward with certainty and control.

Our model is intentionally focused, with smaller, dedicated teams that remain consistent throughout the life of a trial. This continuity ensures deep understanding, stronger relationships, and greater accountability at every stage, delivering  high-quality outcomes with confidence from start to finish. 

The Australian advantage

Australia offers international sponsors an efficient, well-regarded environment for clinical research at every phase.

  • Streamlined regulatory pathway – Many trials proceed under the Therapeutic Goods Administration’s Clinical Trial Notification (CTN) scheme, following review by an accredited Human Research Ethics Committee, with no IND required to begin.
  • Rapid start-up – Efficient ethics and governance processes support fast progression from approval to first participant.
  • Globally accepted data – Data generated to ICH Good Clinical Practice standards is accepted by major regulators, including the US FDA and the European Medicines Agency.
  • R&D Tax Incentive – Eligible companies may claim a tax offset on eligible Australian R&D expenditure, including clinical trial costs, which can be paid as a cash refund for smaller companies.
  • Quality and value – Highly skilled investigators, a diverse population and competitive costs compared with many other major research markets.
  • National reform – Australian governments are investing in national clinical trial reforms, including a National One Stop Shop to further streamline approvals.

Florey Trials pairs these national advantages with direct access to The Florey’s neuroscience ecosystem.

Frequently asked questions

Do you only run early-phase trials?

No. We support trials across Phase I to IV, as well as investigator-initiated studies and medical device trials.

Yes. We work with sponsors from around the world who want to conduct trials in Australia. Where an overseas company has no Australian entity, The Florey can act as the local trial sponsor, and our team guides you through local regulatory, ethics and governance requirements.

Neuroscience is our core focus. We also support trials in adjacent areas where The Florey’s expertise genuinely adds value, such as critical care and neuro-oncology.

Yes. We support Florey researchers and clinician-investigators from protocol development through to trial delivery. Contact us to discuss your study.

Our team

Our team combines clinical operations experience with direct connections to Florey researchers and clinicians, so the people you work with understand both the science behind your trial and the practicalities of delivering it.

  • Adam Pirie
    Adam Pirie PhD EMBA

    Business Development Manager

    Adam connects sponsors with The Florey’s researchers, clinicians, trial teams and infrastructure, bringing scientific rigour and commercial acumen to every partnership.

Contact our team

For enquiries and more information please contact the Florey Trials team.

Please enter your first name
Please enter your last name
Please enter a valid phone number
Please enter a correct email address
Please provide information regarding your enquiry